Muridda has established partnerships with renowned ophthalmic hospitals in Beijing, Shanghai and other regions. We are capable of conducting safety and efficacy evaluations of ophthalmic therapeutic drugs or implantable devices, as well as assessing ocular effects induced by drugs administered via other routes (such as oral administration).
We can perform studies under GLP conditions, provide supportive testing for other GLP-compliant studies, and also conduct non-GLP studies and proof-of-concept (POC) trials to support clients’ early-stage drug research.
Administration Techniques
- Conjunctival sac administration
- Intravitreal administration
- Retrobulbar injection
- Subretinal injection
These cover administration to all segments of the eye, from the anterior segment to the optic nerve.
Animal Species
- Mice, rats, rabbits, monkeys, dogs, pigs
Muridda provides clients with safety evaluation services including general toxicology, safety pharmacology, reproductive and developmental toxicity, genetic toxicology, immunotoxicology, as well as pharmacokinetics and toxicokinetics, covering the entire process from drug discovery to IND and NDA submissions. Through cost-effective and efficient services, we help clients shorten experimental duration and reduce the cost of new drug research and development.
We have a professional team and practical experience in drug safety evaluation, capable of delivering high-quality data and rapid turnaround times to support various drug safety evaluation research. Toxicological studies are conducted in different animal species, and all procedures from dose design, experimental research to histology, pathology and clinical testing can be performed in accordance with non-GLP or GLP standards.